Cerus (CERS) Misses Q2 EPS by 1c, beats revenue, provides guidance

Cerus (NASDAQ: CERS) reported Q2 EPS of ($0.07), $0.01 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $47.7 million versus the consensus estimate of $47.65 million.

GUIDANCE:

Cerus sees FY2023 revenue of $160-165 million.

For earnings history and earnings-related data on Cerus (CERS) click here.

You May Also Be Interested In

• Birkenstock Holding (BIRK) Misses Q3 EPS by 2c; lifts guidance
• Acrivon Therapeutics, Inc. (ACRV) Tops Q2 EPS by 21c
• Lumexa Imaging Holdings, Inc. (LMRI) Reports In-Line Q2 EPS; Offers Guidance